BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci. 2017;372. [PMID: 28893941 DOI: 10.1098/rstb.2016.0274] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Kai K, Komukai S, Koga H, Yamaji K, Ide T, Kawaguchi A, Aishima S, Noshiro H. Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas. World J Gastroenterol 2018; 24(1): 58-68 [PMID: 29358882 DOI: 10.3748/wjg.v24.i1.58] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hu J, Protzer U, Siddiqui A. Revisiting Hepatitis B Virus: Challenges of Curative Therapies. J Virol 2019;93:e01032-19. [PMID: 31375584 DOI: 10.1128/JVI.01032-19] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
3 Penke LR, Peters-Golden M. Molecular determinants of mesenchymal cell activation in fibroproliferative diseases. Cell Mol Life Sci 2019;76:4179-201. [PMID: 31563998 DOI: 10.1007/s00018-019-03212-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Makuza JD, Rwema JOT, Ntihabose CK, Dushimiyimana D, Umutesi J, Nisingizwe MP, Serumondo J, Semakula M, Riedel DJ, Nsanzimana S. Prevalence of hepatitis B surface antigen (HBsAg) positivity and its associated factors in Rwanda. BMC Infect Dis 2019;19:381. [PMID: 31053097 DOI: 10.1186/s12879-019-4013-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
5 Yang P, Zheng Y, Chen J, Ma H, Yu K, Chen Y, Yang Y, Wu B. Immediate risk of non-cancer deaths after a cancer diagnosis. BMC Cancer 2021;21:963. [PMID: 34452598 DOI: 10.1186/s12885-021-08707-6] [Reference Citation Analysis]
6 Wu Z, Wei C, Wang L, He L. Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology. Evid Based Complement Alternat Med 2021;2021:9991533. [PMID: 34306165 DOI: 10.1155/2021/9991533] [Reference Citation Analysis]
7 Beier JI, Arteel GE. Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns. Acta Pharmaceutica Sinica B 2021;11:3768-78. [DOI: 10.1016/j.apsb.2021.09.005] [Reference Citation Analysis]
8 Zhuang Y, Kan Z, Jiang Y, He M, Zhang Y, Sun X, Du M, Wang J, Li Y, Li Y, Zhang L. Constructing an on-demand drug release system composed of thermosensitive PPP hydrogel and drug-laden alginate/graphene microspheres to treat tumorous defect. J Mater Sci. [DOI: 10.1007/s10853-022-06907-4] [Reference Citation Analysis]
9 Wing PA, Davenne T, Wettengel J, Lai AG, Zhuang X, Chakraborty A, D'Arienzo V, Kramer C, Ko C, Harris JM, Schreiner S, Higgs M, Roessler S, Parish JL, Protzer U, Balfe P, Rehwinkel J, McKeating JA. A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis. Life Sci Alliance. 2019;2. [PMID: 30918010 DOI: 10.26508/lsa.201900355] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
10 [DOI: 10.1101/2020.03.27.011841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Benesch MGK, MacIntyre ITK, McMullen TPW, Brindley DN. Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation. Cancers (Basel) 2018;10:E73. [PMID: 29543710 DOI: 10.3390/cancers10030073] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 10.3] [Reference Citation Analysis]
12 Gough NR, Xiang X, Mishra L. TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer. Gastroenterology 2021;161:434-452.e15. [PMID: 33940008 DOI: 10.1053/j.gastro.2021.04.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Pan S, Yu T, Wang Y, Lu R, Wang H, Xie Y, Feng X. Identification of a Torque Teno Mini Virus (TTMV) in Hodgkin's Lymphoma Patients. Front Microbiol 2018;9:1680. [PMID: 30093892 DOI: 10.3389/fmicb.2018.01680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yin L, Sun T, Liu R. NACC-1 regulates hepatocellular carcinoma cell malignancy and is targeted by miR-760. Acta Biochim Biophys Sin (Shanghai) 2020;52:302-9. [PMID: 32091103 DOI: 10.1093/abbs/gmz167] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Cho HJ, Cheong JY. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. Int J Mol Sci 2021;22:8011. [PMID: 34360777 DOI: 10.3390/ijms22158011] [Reference Citation Analysis]
16 Ferreira DA, Tayyar Y, Idris A, McMillan NAJ. A "hit-and-run" affair - A possible link for cancer progression in virally driven cancers. Biochim Biophys Acta Rev Cancer 2021;1875:188476. [PMID: 33186643 DOI: 10.1016/j.bbcan.2020.188476] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
17 Lim HK, Jeffrey GP, Ramm GA, Soekmadji C. Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles. Front Cell Infect Microbiol 2020;10:587628. [PMID: 33240824 DOI: 10.3389/fcimb.2020.587628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Brener L, Cama E, Broady T, Hopwood M, Treloar C. Comparing Australian health worker and student attitudes and concerns about providing care to people living with hepatitis B. Health Promot J Austr 2021. [PMID: 33687771 DOI: 10.1002/hpja.475] [Reference Citation Analysis]
19 DiMaio D, Emu B, Goodman AL, Mothes W, Justice A. Cancer Microbiology. J Natl Cancer Inst 2021:djab212. [PMID: 34850062 DOI: 10.1093/jnci/djab212] [Reference Citation Analysis]
20 Datfar T, Doulberis M, Papaefthymiou A, Hines IN, Manzini G. Viral Hepatitis and Hepatocellular Carcinoma: State of the Art. Pathogens 2021;10:1366. [PMID: 34832522 DOI: 10.3390/pathogens10111366] [Reference Citation Analysis]
21 Lee MH, Ahn SH, Chan HLY, Choudhry A, Alvani Gani R, Mohamed R, Ong JP, Shukla A, Tan CK, Tanwandee T, Thuy PTT, Neo BL, Tsang V, Youn J, Singh S. Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: A large-scale Asian study. J Viral Hepat 2021. [PMID: 34817896 DOI: 10.1111/jvh.13636] [Reference Citation Analysis]
22 Noreen A, Alam N, Syed Z, Aftab A, Shamim F, Najeebullah S, Khan D, Kakar SJ, Ahmed T, Adnan F. Prevalence and assessment of the associated risk factors of hepatitis B and C infections in the low socioeconomic communities. Future Virology. [DOI: 10.2217/fvl-2021-0060] [Reference Citation Analysis]
23 Shpichka A, Bikmulina P, Peshkova M, Kosheleva N, Zurina I, Zahmatkesh E, Khoshdel-Rad N, Lipina M, Golubeva E, Butnaru D, Svistunov A, Vosough M, Timashev P. Engineering a Model to Study Viral Infections: Bioprinting, Microfluidics, and Organoids to Defeat Coronavirus Disease 2019 (COVID-19). Int J Bioprint 2020;6:302. [PMID: 33089000 DOI: 10.18063/ijb.v6i4.302] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
24 de Castro GLC, Bichara CDA, Santiago AM, de Brito WB, Pereira LMS, Moura TCF, da Silva Graça Amoras E, de Araújo MSM, da Silva Conde SRS, Queiroz MAF, Ishak R, Vallinoto ACR. Polymorphisms in the TGFB1 and FOXP3 genes are associated with the presence of antinuclear antibodies in chronic hepatitis C. Heliyon 2020;6:e04524. [PMID: 32743104 DOI: 10.1016/j.heliyon.2020.e04524] [Reference Citation Analysis]
25 Nsibirwa S, Anguzu G, Kamukama S, Ocama P, Nankya-Mutyoba J. Herbal medicine use among patients with viral and non-viral Hepatitis in Uganda: prevalence, patterns and related factors. BMC Complement Med Ther 2020;20:169. [PMID: 32493310 DOI: 10.1186/s12906-020-02959-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yahya EB, Alqadhi AM. Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sci 2021;269:119087. [PMID: 33476633 DOI: 10.1016/j.lfs.2021.119087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
27 Ren Y, Yang L, Li M, Wang J, Yan H, Ma N, Liu W, Wang L, Gao X, Gao P, Li T, Liu D. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients. Sci Rep 2021;11:16982. [PMID: 34417517 DOI: 10.1038/s41598-021-96581-4] [Reference Citation Analysis]
28 Ramli S, Sim MS, Guad RM, Gopinath SCB, Subramaniyan V, Fuloria S, Fuloria NK, Choy KW, Rana S, Wu YS. Long Noncoding RNA UCA1 in Gastrointestinal Cancers: Molecular Regulatory Roles and Patterns, Mechanisms, and Interactions. J Oncol 2021;2021:5519720. [PMID: 33936199 DOI: 10.1155/2021/5519720] [Reference Citation Analysis]
29 Ladouceur A, Bernatsky S, Ramsey-goldman R, Clarke AE. Managing cancer risk in patients with systemic lupus erythematous. Expert Review of Clinical Immunology 2018;14:793-802. [DOI: 10.1080/1744666x.2018.1519394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mane A, Sacks J, Sharma S, Singh H, Tejada-Strop A, Kamili S, Kacholia K, Gautam R, Thakar M, Gupta RS, Gangakhedkar R. Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): A step towards scale-up of HCV screening efforts in India. PLoS One 2019;14:e0210556. [PMID: 30653562 DOI: 10.1371/journal.pone.0210556] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
31 Shi Y, Du L, Lv D, Li Y, Zhang Z, Huang X, Tang H. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases. J Gastroenterol 2021;56:336-49. [PMID: 33665710 DOI: 10.1007/s00535-021-01765-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Wang Y, Wang L, Yu X, Duan J. Overexpression of miR-450 affects the biological behavior of HepG2 cells by targeting DNMT3a. Onco Targets Ther 2019;12:5069-76. [PMID: 31303764 DOI: 10.2147/OTT.S203206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
33 Patil VS, Harish DR, Vetrivel U, Roy S, Deshpande SH, Hegde HV. Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula: A Structural Perspective. Molecules 2022;27:1076. [DOI: 10.3390/molecules27031076] [Reference Citation Analysis]
34 D'silva M, Cho JY, Han H, Yoon Y, Lee HW, Lee JS, Lee B, Kim M. Long-term surgical outcomes of Non alcoholic fatty liver disease associated hepatocellular carcinoma. Surgical Oncology 2022;41:101730. [DOI: 10.1016/j.suronc.2022.101730] [Reference Citation Analysis]
35 Liu PJ, Balfe P, McKeating JA, Schilling M. Oxygen Sensing and Viral Replication: Implications for Tropism and Pathogenesis. Viruses 2020;12:E1213. [PMID: 33113858 DOI: 10.3390/v12111213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Li X, Yuan M, Song L, Wang Y. Silencing of microRNA-210 inhibits the progression of liver cancer and hepatitis B virus-associated liver cancer via targeting EGR3. BMC Med Genet 2020;21:48. [PMID: 32138690 DOI: 10.1186/s12881-020-0974-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
37 Nankya-Mutyoba J, Aizire J, Makumbi F, Atuyambe L, Ocama P, Kirk GD. Correlates of hepatitis B awareness and disease-specific knowledge among pregnant women in Northern and Central Uganda: a cross-sectional study. Hepatol Med Policy 2018;3:14. [PMID: 30598844 DOI: 10.1186/s41124-018-0043-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Barde PV, Chouksey VK, Shivlata L, Sahare LK, Thakur AK. Viral hepatitis among acute hepatitis patients attending tertiary care hospital in central India. Virusdisease 2019;30:367-72. [PMID: 31803803 DOI: 10.1007/s13337-019-00541-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
39 Al Mamun A, Akter A, Hossain S, Sarker T, Safa SA, Mustafa QG, Muhammad SA, Munir F. Role of NLRP3 inflammasome in liver disease. J Dig Dis 2020;21:430-6. [PMID: 32585073 DOI: 10.1111/1751-2980.12918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Kobia F, Gitaka J, Makokha F, Kamita M, Kibera J, Mwenda C, Mucee G, Kilingo B. The state of cancer in Meru, Kenya: a retrospective study. AAS Open Res 2019;2:167. [DOI: 10.12688/aasopenres.13027.1] [Reference Citation Analysis]
41 Li Y, Zhou J, Li T. Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment. Front Mol Biosci 2022;9:879817. [DOI: 10.3389/fmolb.2022.879817] [Reference Citation Analysis]
42 Ringelhan M, Pfister D, O'Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19:222-232. [PMID: 29379119 DOI: 10.1038/s41590-018-0044-z] [Cited by in Crossref: 281] [Cited by in F6Publishing: 289] [Article Influence: 70.3] [Reference Citation Analysis]
43 D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
44 Zhang C, Li J, Yang L, Xu F, She H, Liu X. Transcriptome Classification Reveals Molecular Subgroups in Patients with Hepatitis B Virus. Comput Math Methods Med 2021;2021:5543747. [PMID: 33859718 DOI: 10.1155/2021/5543747] [Reference Citation Analysis]
45 Wang Y, Li C, Shi Y, Kuai J. LncRNA NKILA Promotes Epithelial-Mesenchymal Transition of Liver Cancer Cells by Targeting miR-485-5p. J Oncol 2021;2021:1281031. [PMID: 34512751 DOI: 10.1155/2021/1281031] [Reference Citation Analysis]
46 Figgatt M, Hildick-Smith J, Addish E, Coleman J, Benitez J, Freeland C, Alles S, Viner K, Johnson C, Kuncio D. Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018. Public Health Rep 2020;135:691-9. [PMID: 32791034 DOI: 10.1177/0033354920943528] [Reference Citation Analysis]
47 Krishnamurthy S, Gilot D, Ahn SB, Lam V, Shin JS, Guillemin GJ, Heng B. Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5180. [PMID: 34680327 DOI: 10.3390/cancers13205180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Maniewska J, Jeżewska D. Non-Steroidal Anti-Inflammatory Drugs in Colorectal Cancer Chemoprevention. Cancers (Basel) 2021;13:594. [PMID: 33546238 DOI: 10.3390/cancers13040594] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Almaeen AH, Alduraywish AA, Mobasher MA, Almadhi OIM, Nafeh HM, El-Metwally TH. Oxidative stress, immunological and cellular hypoxia biomarkers in hepatitis C treatment-naïve and cirrhotic patients. Arch Med Sci 2021;17:368-75. [PMID: 33747272 DOI: 10.5114/aoms.2019.91451] [Reference Citation Analysis]
50 Baghdadi I, Abu Ella K, El Shaaraway A, Elshayeb E, El-Rebey HS, El Hoseeny M, Naguib M, Nada A. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients. Asian Pac J Cancer Prev 2020;21:2047-53. [PMID: 32711431 DOI: 10.31557/APJCP.2020.21.7.2047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Yeasmin S, Ammanath G, Ali Y, Boehm BO, Yildiz UH, Palaniappan A, Liedberg B. Colorimetric Urinalysis for On-Site Detection of Metabolic Biomarkers. ACS Appl Mater Interfaces 2020;12:31270-81. [DOI: 10.1021/acsami.0c09179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Glass MC, Smith JM, Cheng HH, Delany ME. Marek's Disease Virus Telomeric Integration Profiles of Neoplastic Host Tissues Reveal Unbiased Chromosomal Selection and Loss of Cellular Diversity during Tumorigenesis. Genes (Basel) 2021;12:1630. [PMID: 34681024 DOI: 10.3390/genes12101630] [Reference Citation Analysis]
53 Ashfaq W, Rehman K, Siddique MI, Khan Q. Eicosapentaenoic Acid and Docosahexaenoic Acid from Fish Oil and Their Role in Cancer Research. Food Reviews International 2020;36:795-814. [DOI: 10.1080/87559129.2019.1686761] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Zhang L, Rong W, Ma J, Li H, Tang X, Xu S, Wang L, Wan L, Zhu Q, Jiang B, Su F, Cui H. Comprehensive Analysis of DNA 5-Methylcytosine and N6-Adenine Methylation by Nanopore Sequencing in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:827391. [DOI: 10.3389/fcell.2022.827391] [Reference Citation Analysis]
55 Nguyen ALT, Nguyen HTT, Yee KC, Palmer AJ, Blizzard CL, de Graaff B. A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening Strategies. Value Health 2021;24:733-43. [PMID: 33933243 DOI: 10.1016/j.jval.2020.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Ibrahim MA, Abdel-Aziz A, El-Sheikh A, Kamel M, Khalil AZ, Abdelhaleem H. Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats. Clin Exp Hepatol 2018;4:175-81. [PMID: 30324142 DOI: 10.5114/ceh.2018.78121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
57 Weiskirchen R, Weiskirchen S, Tacke F. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Res 2018;7:F1000 Faculty Rev-921. [PMID: 30002817 DOI: 10.12688/f1000research.14841.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
58 Khoshdel-Rad N, Zahmatkesh E, Bikmulina P, Peshkova M, Kosheleva N, Bezrukov EA, Sukhanov RB, Solovieva A, Shpichka A, Timashev P, Vosough M. Modeling Hepatotropic Viral Infections: Cells vs. Animals. Cells 2021;10:1726. [PMID: 34359899 DOI: 10.3390/cells10071726] [Reference Citation Analysis]
59 El-shaarawy F, Abo Elazm MM, Mohamed RH, Radwan MI, Abo-elmatty DM, Mehanna ET. Relation of the methylation state of RUNX3 and p16 gene promoters with hepatocellular carcinoma in Egyptian patients. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00256-2] [Reference Citation Analysis]
60 Huang X, Qiu Z, Li L, Chen B, Huang P. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Aging (Albany NY) 2021;13:20698-715. [PMID: 34461607 DOI: 10.18632/aging.203456] [Reference Citation Analysis]
61 Lian J, Zou Y, Huang L, Cheng H, Huang K, Zeng J, Chen L. Hepatitis B virus upregulates cellular inhibitor of apoptosis protein 2 expression via the PI3K/AKT/NF-κB signaling pathway in liver cancer. Oncol Lett 2020;19:2043-52. [PMID: 32194701 DOI: 10.3892/ol.2020.11267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Esposito A, Buscarino V, Raciti D, Casiraghi E, Manini M, Biondetti P, Forzenigo L. Characterization of liver nodules in patients with chronic liver disease by MRI: performance of the Liver Imaging Reporting and Data System (LI-RADS v.2018) scale and its comparison with the Likert scale. Radiol Med 2020;125:15-23. [PMID: 31587182 DOI: 10.1007/s11547-019-01092-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
63 Lee SA, Liu F, Riordan SM, Lee CS, Zhang L. Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer. Front Oncol 2019;9:566. [PMID: 31334107 DOI: 10.3389/fonc.2019.00566] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
64 Phan DV, Chan CL, Li AA, Chien TY, Nguyen VC. Liver cancer prediction in a viral hepatitis cohort: A deep learning approach. Int J Cancer 2020;147:2871-8. [PMID: 32761609 DOI: 10.1002/ijc.33245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Desai HD, Ansari AAZ, Makwana D, Jadeja DM, Gusani J. Clinical-biochemical profile and etiology of acute viral hepatitis in hospitalized young adults at tertiary care center. J Family Med Prim Care 2020;9:247-52. [PMID: 32110599 DOI: 10.4103/jfmpc.jfmpc_727_19] [Reference Citation Analysis]
66 Mahoney KE, Shabanowitz J, Hunt DF. MHC Phosphopeptides: Promising Targets for Immunotherapy of Cancer and Other Chronic Diseases. Mol Cell Proteomics 2021;20:100112. [PMID: 34129940 DOI: 10.1016/j.mcpro.2021.100112] [Reference Citation Analysis]
67 Chang MH, Kuo YJ, Ho CY, Kuan EC, Lan MY. Metastatic Tumors of the Sinonasal Cavity: A 15-Year Review of 17 Cases. J Clin Med 2019;8:E539. [PMID: 31010194 DOI: 10.3390/jcm8040539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
68 Hassanipour S, Mohammadzadeh M, Mansour-Ghanaei F, Fathalipour M, Joukar F, Salehiniya H, Abdzadeh E, Samadani AA, Nikbakht HA, Arab-Zozani M. The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis. J Gastrointest Cancer 2019;50:193-200. [PMID: 30725358 DOI: 10.1007/s12029-019-00207-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
69 Zhang N, Wang Z, Lv J, Zhang S, Liu Y, Liu T, Li W, Gong L, Zhang X, El-omar EM, Lu W. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion. Front Med 2022;9:836369. [DOI: 10.3389/fmed.2022.836369] [Reference Citation Analysis]
70 Patten DA, Wilkinson AL, O'Keeffe A, Shetty S. Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer. Semin Liver Dis 2021. [PMID: 34553345 DOI: 10.1055/s-0041-1733876] [Reference Citation Analysis]
71 Irani S, Barati I, Badiei M. Periodontitis and oral cancer - current concepts of the etiopathogenesis. Oncol Rev 2020;14:465. [PMID: 32231765 DOI: 10.4081/oncol.2020.465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
72 Wang S, Gao S, Li Y, Qian X, Luan J, Lv X. Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease. Front Cell Dev Biol 2021;9:716842. [PMID: 34386499 DOI: 10.3389/fcell.2021.716842] [Reference Citation Analysis]
73 Chaturvedi VK, Singh A, Dubey SK, Hetta HF, John J, Singh M. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microbial Pathogenesis 2019;128:184-94. [DOI: 10.1016/j.micpath.2019.01.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
74 Almeida PH, Matielo CEL, Curvelo LA, Rocco RA, Felga G, Della Guardia B, Boteon YL. Update on the management and treatment of viral hepatitis. World J Gastroenterol 2021; 27(23): 3249-3261 [PMID: 34163109 DOI: 10.3748/wjg.v27.i23.3249] [Reference Citation Analysis]
75 Sun M, Chang C, Lu C, Wu S, Zhang J. Sarcopenia as an Independent Risk Factor for Specific Cancers: A Propensity Score-Matched Asian Population-Based Cohort Study. Nutrients 2022;14:1910. [DOI: 10.3390/nu14091910] [Reference Citation Analysis]
76 Liu Q, Zhu F, Shi Y, Zhang D. Immune Profile of Mucosal-Associated Invariant T Cells in Chronic Viral Hepatitis: A Systematic Review and Meta-Analysis. Hepat Mon 2019;19. [DOI: 10.5812/hepatmon.94377] [Reference Citation Analysis]
77 Fezza M, Moussa M, Aoun R, Haber R, Hilal G. DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1. PLoS One 2019;14:e0223252. [PMID: 31568519 DOI: 10.1371/journal.pone.0223252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
78 Chen S, Guo L, Wang Z, Mao W, Ge Y, Ying X, Fang J, Long Q, Liu Q, Xiang H, Wu C, Fu C, Dong D, Zhang J, Sun J, Tian L, Wang L, Zhou M, Zhang M, Qian M, Liu W, Jiang W, Feng W, Zeng X, Ding X, Lei X, Tolhurst R, Xu L, Wang H, Ziegeweid F, Glenn S, Ji JS, Story M, Yamey G, Tang S. Current situation and progress toward the 2030 health-related Sustainable Development Goals in China: A systematic analysis. PLoS Med 2019;16:e1002975. [PMID: 31743352 DOI: 10.1371/journal.pmed.1002975] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
79 Adelakun AA, Adediji IO, Idowu OJ, Jegede TF, Oluremi AS, Adepoju PO, Olaniyan OA. Prognostic significance of serum telomerase activity in the monitoring of hepatitis B viral infection. J Immunoassay Immunochem 2021;:1-9. [PMID: 34861808 DOI: 10.1080/15321819.2021.2004162] [Reference Citation Analysis]
80 von Olshausen G, Quasdorff M, Bester R, Arzberger S, Ko C, van de Klundert M, Zhang K, Odenthal M, Ringelhan M, Niessen CM, Protzer U. Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashion. Oncotarget 2018;9:33947-60. [PMID: 30338037 DOI: 10.18632/oncotarget.26103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
81 Lee SR, Jeong SH, Heo JH, Jo SL, Ko JW, Kwun HJ, Hong EJ. Dietary Intake of 17α-Ethinylestradiol Promotes HCC Progression in Humanized Male Mice Expressing Sex Hormone-Binding Globulin. Int J Mol Sci 2021;22:12557. [PMID: 34830439 DOI: 10.3390/ijms222212557] [Reference Citation Analysis]
82 Schwartz L, Peres S, Jolicoeur M, da Veiga Moreira J. Cancer and Alzheimer's disease: intracellular pH scales the metabolic disorders. Biogerontology 2020;21:683-94. [PMID: 32617766 DOI: 10.1007/s10522-020-09888-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
83 Zehetner V, Cavalleri JV, Klang A, Hofer M, Preining I, Steinborn R, Ramsauer AS. Equine Parvovirus-Hepatitis Screening in Horses and Donkeys with Histopathologic Liver Abnormalities. Viruses 2021;13:1599. [PMID: 34452465 DOI: 10.3390/v13081599] [Reference Citation Analysis]
84 Suares A, Medina MV, Coso O. Autophagy in Viral Development and Progression of Cancer. Front Oncol 2021;11:603224. [PMID: 33763351 DOI: 10.3389/fonc.2021.603224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Yin L, Cai Z, Zhu B, Xu C. Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA. Genes (Basel) 2018;9:E92. [PMID: 29443924 DOI: 10.3390/genes9020092] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 14.5] [Reference Citation Analysis]
86 Wong RSY. Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Cancer Prevention and Cancer Promotion. Adv Pharmacol Sci 2019;2019:3418975. [PMID: 30838040 DOI: 10.1155/2019/3418975] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
87 Hoan NX, Hoechel M, Tomazatos A, Anh CX, Pallerla SR, Linh LTK, Binh MT, Sy BT, Toan NL, Wedemeyer H, Bock CT, Kremsner PG, Meyer CG, Song LH, Velavan TP. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis. Viruses 2021;13:346. [PMID: 33671832 DOI: 10.3390/v13020346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J 2019;10:365-81. [PMID: 31832112 DOI: 10.1007/s13167-019-00194-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 19.0] [Reference Citation Analysis]
89 Dong J, Ma Q. Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes. Nanotoxicology 2019;13:1244-74. [PMID: 31537143 DOI: 10.1080/17435390.2019.1651920] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
90 Chen LY, Hwang AC, Huang CY, Chen LK, Wang FD, Chan YJ. CMV infection, CD19+ B cell depletion, and Lymphopenia as predictors for unexpected admission in the institutionalized elderly. Immun Ageing 2021;18:21. [PMID: 33947427 DOI: 10.1186/s12979-021-00233-0] [Reference Citation Analysis]
91 Kamali I, Barnhart DA, Ndahimana JD, Noor K, Mumporeze J, Nyirahabihirwe F, Gakuru JP, Musafiri T, Urusaro S, Makuza JD, Serumondo J, Rwamuhinda DD, Nkundibiza M, Kateera F, Nshogoza GR, Mubiligi JM. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study. PLoS One 2021;16:e0257917. [PMID: 34634039 DOI: 10.1371/journal.pone.0257917] [Reference Citation Analysis]
92 James WH, Grech V. Can sex ratios at birth be used in the assessment of public health, and in the identification of causes of selected pathologies? Early Hum Dev 2018;118:15-21. [PMID: 29428574 DOI: 10.1016/j.earlhumdev.2018.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Chen M, Wu HL, Wong TS, Chen B, Gong RH, Wong HLX, Xiao H, Bian Z, Kwan HY. Combination of Wogonin and Artesunate Exhibits Synergistic anti-Hepatocellular Carcinoma Effect by Increasing DNA-Damage-Inducible Alpha, Tumor Necrosis Factor α and Tumor Necrosis Factor Receptor-Associated Factor 3-mediated Apoptosis. Front Pharmacol 2021;12:657080. [PMID: 34025421 DOI: 10.3389/fphar.2021.657080] [Reference Citation Analysis]
94 Boyer-Diaz Z, Morata P, Aristu-Zabalza P, Gibert-Ramos A, Bosch J, Gracia-Sancho J. Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical. Nutrients 2020;12:E2627. [PMID: 32872239 DOI: 10.3390/nu12092627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
95 Kori M, Arga KY. Pathways involved in viral oncogenesis: New perspectives from virus-host protein interactomics. Biochim Biophys Acta Mol Basis Dis 2020;1866:165885. [PMID: 32574835 DOI: 10.1016/j.bbadis.2020.165885] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
96 Kim SH, Seung BJ, Cho SH, Lim HY, Bae MK, Sur JH. Arginase-1 and P-glycoprotein are downregulated in canine hepatocellular carcinoma. J Vet Sci 2021;22:e61. [PMID: 34423599 DOI: 10.4142/jvs.2021.22.e61] [Reference Citation Analysis]
97 Castro GLC, Amoras EDGS, Araújo MSM, Conde SRSDS, Vallinoto ACR. Hepatitis C virus genotypes and associated risk factors in the state of Pará, Northern Brazil. Braz J Infect Dis 2020;24:304-9. [PMID: 32735876 DOI: 10.1016/j.bjid.2020.06.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Lu H, Zhu Q. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach. Cancer Biother Radiopharm 2020. [PMID: 32598174 DOI: 10.1089/cbr.2019.3327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Ma Y, Frutos-Beltrán E, Kang D, Pannecouque C, De Clercq E, Menéndez-Arias L, Liu X, Zhan P. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chem Soc Rev 2021;50:4514-40. [PMID: 33595031 DOI: 10.1039/d0cs01084g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
100 Chen D, Feng X, Lv Z, Xu X, Lu Y, Wu W, Wu H, Liu H, Cao L, Ye S, Chen J, Wu J. ACADS acts as a potential methylation biomarker associated with the proliferation and metastasis of hepatocellular carcinomas. Aging (Albany NY) 2019;11:8825-44. [PMID: 31652420 DOI: 10.18632/aging.102292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
101 Yang W, Terry MB. Do Temporal Trends in Cancer Incidence Reveal Organ System Connections for Cancer Etiology? Epidemiology 2020;31:595-8. [PMID: 32221269 DOI: 10.1097/EDE.0000000000001192] [Reference Citation Analysis]
102 Singh R. Single-Cell Sequencing in Human Genital Infections. Adv Exp Med Biol 2020;1255:203-20. [PMID: 32949402 DOI: 10.1007/978-981-15-4494-1_17] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Ding Y, Cao L, Zhu L, Huang Y, Lin C, Wang Y, Liu Y, Sheng Q, Wang S, Fan J, Chen R, Gan W, Chen B, Pan CQ. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study. Aliment Pharmacol Ther 2020;52:1377-86. [PMID: 32852100 DOI: 10.1111/apt.16043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
104 Chang Y, Moore PS, Weiss RA. Human oncogenic viruses: nature and discovery. Philos Trans R Soc Lond B Biol Sci. 2017;372. [PMID: 28893931 DOI: 10.1098/rstb.2016.0264] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
105 Tang H, Abouleila Y, Si L, Ortega-Prieto AM, Mummery CL, Ingber DE, Mashaghi A. Human Organs-on-Chips for Virology. Trends Microbiol 2020;28:934-46. [PMID: 32674988 DOI: 10.1016/j.tim.2020.06.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 19.5] [Reference Citation Analysis]
106 Yeh H, Chiang CC, Yen TH. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World J Gastroenterol 2021; 27(26): 4104-4142 [PMID: 34326614 DOI: 10.3748/wjg.v27.i26.4104] [Reference Citation Analysis]
107 Cao C, Li J, Li G, Hu G, Deng Z, Huang B, Yang J, Li J, Cao S. Long Non-coding RNA TMEM220-AS1 Suppressed Hepatocellular Carcinoma by Regulating the miR-484/MAGI1 Axis as a Competing Endogenous RNA. Front Cell Dev Biol 2021;9:681529. [PMID: 34422806 DOI: 10.3389/fcell.2021.681529] [Reference Citation Analysis]
108 Tian H, He Z. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity. Biomed Pharmacother 2018;99:774-80. [PMID: 29710475 DOI: 10.1016/j.biopha.2018.01.141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
109 Calise SJ, Chan EKL. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery. Autoimmun Rev 2020;19:102643. [PMID: 32805424 DOI: 10.1016/j.autrev.2020.102643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
110 Mou D, Yang X, Li S, Zhao W, Li M, Zhao M, Alotaibi NH, Zhang Z, Tang M, Alharbi KS, Bahman J, Bukhari SNA, Dézlla C. MG132 inhibits the expression of PBX3 through miRNAs by targeting Argonaute2 in hepatoma cells. Saudi J Biol Sci 2020;27:2157-63. [PMID: 32714042 DOI: 10.1016/j.sjbs.2020.06.008] [Reference Citation Analysis]
111 Zhu Q, Yu X, Zhou ZW, Luo M, Zhou C, He ZX, Chen Y, Zhou SF. A quantitative proteomic response of hepatocellular carcinoma Hep3B cells to danusertib, a pan-Aurora kinase inhibitor. J Cancer 2018;9:2061-71. [PMID: 29937924 DOI: 10.7150/jca.20822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
112 Sufleţel RT, Melincovici CS, Gheban BA, Toader Z, Mihu CM. Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. Rom J Morphol Embryol 2020;61:615-42. [PMID: 33817704 DOI: 10.47162/RJME.61.3.01] [Reference Citation Analysis]
113 Ely A, Bloom K, Maepa MB, Arbuthnot P. Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1-17. [PMID: 33542907 DOI: 10.2147/JHC.S268291] [Reference Citation Analysis]
114 Bieńkowski C, Kowalczyk M, Pluta M, Pokorska-Śpiewak M. Acute Hepatitis B and Unusual Follow-Up in a 16-Year-Old Boy: Case Report. Pediatr Rep 2021;13:534-7. [PMID: 34564345 DOI: 10.3390/pediatric13030062] [Reference Citation Analysis]
115 Desikan P, Rangnekar A, Khan Z, Panwalkar N, Bose P, Gulwani HV, Kaur S. Sero-Occurrence of HBV/HCV Co-infection and Levels of Liver Enzymes among Patients at a Tertiary Care Hospital in Central India: a Pilot Study. Cent Asian J Glob Health 2019;8:313. [PMID: 31321151 DOI: 10.5195/cajgh.2019.313] [Reference Citation Analysis]
116 Li T, Su S, Zhao Y, Deng R, Fan M, Wang R, Sharma M, Zeng H. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. Int J Environ Res Public Health 2019;16:E231. [PMID: 30650581 DOI: 10.3390/ijerph16020231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
117 Lin Z, Xu Q, Song X, Zeng Y, Zeng L, Zhao L, Xu J, Miao D, Chen Z, Yu F. Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma. Front Oncol 2022;12:748557. [DOI: 10.3389/fonc.2022.748557] [Reference Citation Analysis]